Back to Search
Start Over
CSF neopterin as a biomarker of treatment response to JAK inhibition in Aicardi–Goutières syndrome
- Source :
- Han, V X, Mohammad, S S, Jones, H F, Bandodkar, S, Crow, Y J 2021, ' CSF neopterin as a biomarker of treatment response to JAK inhibition in Aicardi–Goutières syndrome ', Developmental Medicine & Child Neurology (DMCN) . https://doi.org/10.1111/dmcn.15025
- Publication Year :
- 2021
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Han, V X, Mohammad, S S, Jones, H F, Bandodkar, S, Crow, Y J 2021, ' CSF neopterin as a biomarker of treatment response to JAK inhibition in Aicardi–Goutières syndrome ', Developmental Medicine & Child Neurology (DMCN) . https://doi.org/10.1111/dmcn.15025
- Accession number :
- edsair.od......3094..f9a0ef2b0e96a9ae5bbad088547d0bf1